These results suggest that the deficient production of cytokines (IL-6, IL-8, and GRO-β) in CMML-BMSCs may be partially implicated in the pathological hematopoiesis in patients with CMML. The gene discussed is CXCL8; the disease is chronic myelomonocytic leukemia.